A carregar...

PRAZOSIN FOR THE TREATMENT OF BEHAVIORAL SYMPTOMS IN ALZHEIMER’S DISEASE PATIENTS WITH AGITATION AND AGGRESSION

OBJECTIVES: Agitation and aggression in Alzheimer’s disease (AD) is a major cause of patient distress, caregiver burden, and institutionalization. Enhanced behavioral responsiveness to central nervous system norepinephrine release may contribute to the pathophysiology of agitation and aggression in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wang, Lucy Y., Shofer, Jane B., Rohde, Kirsten, Hart, Kim L., Hoff, David J., McFall, Yun H., Raskind, Murray A., Peskind, Elaine R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2842091/
https://ncbi.nlm.nih.gov/pubmed/19700947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JGP.0b013e3181ab8c61
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!